243 results
P
ALS patients
I/C
genome-wide association studies (GWASs), different ancestry
O
no ALS risk association
P
Al exposed, unexposed
I/C
Chronic Al exposure
O
Cognitive function, Memory, Processing speed, Working memory
P
patients with allergic rhinitis
I/C
oral H, placebo
O
total symptom score reduction, nasal congestion score reduction, rhinorrhea score reduction, ocular symptom score reduction, nasal itching score reduction, sneezing score reduction
P
patients with amyotrophic lateral sclerosis (ALS)
I/C
uric acid (UA) levels, hazard ratio-based studies
O
prognostic biomarker for ALS
P
541 participants
I/C
periodontal treatment, conventional systemic H. pylori eradication therapy alone
O
gastric H. pylori eradication rates
P
animals
I/C
hypothermic machine perfusion, subnormothermic machine perfusion, warm ischemia without cold storage, normothermic machine perfusion, static cold storage (< 12 h), warm ischemia without cold storage, normothermic machine perfusion, static cold storage (< 12 h), static cold storage (≥ 12 h)
O
ATP content, respiratory activity of mitochondrial complexes, cytochrome c release, aspartate aminotransferase (ALT) release
P
working-age (≥15 years) workers in the formal and informal economy
I/C
exposure to long working hours (41-48, 49-54 and ≥55 h/week), exposure to standard working hours (35-40 h/week)
O
depression (prevalence, incidence and mortality)
P
patients with amyotrophic lateral sclerosis (ALS)
I/C
systematic search of PubMed, EMBASE, OVID and other databases, split hand syndrome
O
frequency of split hand sign in ALS patients
P
Helicobacter pylori (H. pylori) positive peptic ulcer disease (PUD)
I/C
Chinese herbal formulae, conventional triple therapy (CON)
O
eradication rate, clinical efficiency, recurrence rate
P
adult individuals
I/C
low-sodium salt substitute (LSSS), no LSSS
O
lower 24-h urinary sodium excretion